JENNIFER MABRY: Open Payments
NPI 1649803081 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 58 payments from 19 companies in 2025. Trend: 2023 $1,114 · 2024 $1,099 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $178 |
| AstraZeneca Pharmaceuticals LP | 9 | $147 |
| ABBVIE INC. | 6 | $105 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Lilly USA, LLC | 3 | $60 |
| Amgen Inc. | 4 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| PFIZER INC. | 3 | $48 |
| Abbott Laboratories | 2 | $36 |
| Dexcom, Inc. | 2 | $36 |
Products named: SHINGRIX, AIRSUPRA, GARDASIL 9, UBRELVY, JARDIANCE, MOUNJARO, FREESTYLE LIBRE 3, Dexcom G6 Transmitter.
Industry payments across AZ — which companies pay providers there.
